Shares of Day One Biopharmaceuticals (NASDAQ: DAWN) have surged over 50% in the last three months, reigniting debate over its fair value and the risks tied to its lead drug OJEMDA and a pivotal upcoming data readout.
Imperial Oil Ltd. reported robust fourth-quarter results, generating nearly $1.4 billion in free cash flow and announcing its largest-ever nominal dividend increase. Despite weather disruptions at its Kearl oil sands operation, the company highlighted record annual production and a disciplined capital return strategy that saw $4.6 billion returned to shareholders in 2025.
EMCOR Group (NYSE: EME) has revised its 2025 outlook upward, buoyed by a series of strategic acquisitions and robust organic performance. While the stock's impressive run continues, analysts are weighing the sustainability of its growth strategy against a premium valuation.
The U.S. Air Force Research Laboratory has awarded Palladyne AI a contract for its HANGTIME project, marking a significant expansion of the company's autonomous swarm software from ground and air assets into the space domain. The deal validates the company's core technology but comes as investors weigh its growth potential against ongoing financial challenges.
Facing softer demand and tariff volatility, Minerals Technologies (MTX) reported steady 2025 sales of $2.1B but saw margins contract. Leadership emphasized cost discipline and safety while detailing a series of expansion projects poised to drive a meaningful rebound in the coming year.
Kirby Corporation (KEX), a leading tank barge operator, is attracting significant institutional capital amid strong quarterly results and optimistic guidance, with its stock rising 11% year-to-date.
Amidst a major brand refresh for Terrapin Beer and the announcement of SweetWater Brewing's 2026 festival lineup, Tilray Brands is aggressively pushing its beverage division into the mainstream. However, this consumer-facing drive contrasts sharply with a prolonged stock slump, raising critical questions about the company's true market value and future trajectory.
The $10 to $50 per share range is a hunting ground for investors seeking established, mid-sized companies with growth potential. While often less volatile than penny stocks, they are not without risk. We analyze one stock with promising upside and two facing significant headwinds.
While stocks priced between $10 and $50 often signal companies past their initial hurdles, they can also mask underlying vulnerabilities. We analyze three such stocks—Figs, Array Technologies, and Kforce—that currently present significant risks to investors, despite their seemingly accessible price tags.
Kratos Defense & Security Solutions (KTOS) has seen its stock price surge dramatically over the past six months, fueled by strong quarterly performance. However, a closer look at its cash flow, capital efficiency, and valuation suggests investors should proceed with caution. We analyze the risks and highlight a more compelling alternative in the security sector.
While lofty price targets can signal opportunity, a closer look reveals that not all consensus forecasts are created equal. We examine one company poised to deliver and two where investor caution may be warranted.
As SpaceX reportedly engages banks for a potential 2026 public offering, the pre-IPO secondary market for late-stage tech giants is booming, offering a critical liquidity valve and reshaping the path to going public.
A Florida couple is suing their fertility clinic after discovering the baby girl born via IVF is not genetically related to them, sparking a complex legal and ethical battle over parentage and clinic accountability.
A new report reveals a staggering 67% of purchased sales software features go unused, spotlighting a critical disconnect between tech spending and revenue impact. As IT budgets swell, C-suite leaders are urged to shift from measuring adoption to calculating true dollar-for-dollar returns.
On-chain data reveals a notable shift in crypto whale activity, with large-scale accumulation emerging in Shiba Inu, Pendle, and Cardano. This strategic positioning coincides with early technical signals hinting at potential rebounds, setting the stage for a pivotal February.
Elon Musk is reportedly in discussions to merge his aerospace giant SpaceX with his artificial intelligence venture xAI, aiming to create an integrated powerhouse for deploying AI data centers in orbit, powered by space solar energy.
Congress has approved $23 billion in initial funding for the ambitious Golden Dome missile defense initiative, yet the absence of a detailed spending blueprint from the Pentagon is stalling progress and clouding investment prospects for 2026.
In a significant policy shift, Chinese authorities have reportedly cleared the AI startup DeepSeek to purchase Nvidia's advanced H200 processors, potentially easing a major hardware bottleneck for its competitive large language model.
As SpaceX targets a record-shattering IPO for mid-2026, reports indicate Elon Musk is exploring a potential merger with either Tesla or his AI startup, xAI. The move could create a unified tech and industrial behemoth but faces significant regulatory and operational hurdles.
ASGN reaffirms strong Q4 2025 revenue guidance and launches a dual-pronged strategy: a $290 million cash acquisition of AI-focused consultancy Quinnox and a $1 billion share repurchase program. The moves signal a decisive shift towards high-value AI and digital implementation services, even as the company navigates elevated debt and integration challenges under its new Everforth brand.
